Table 4.
New Stroke | Mortality | Neurologic deterioration | GOS ≤ 3 | |
---|---|---|---|---|
Unadjusted Model* | ||||
K55R | 5.04 (1.45– 17.52) | 7.2 (1.39–37.19) | 0.47 (0.12–1.86) | 1.35 (.38–4.86) |
R287Q | 0.56 (0.16 – 1.91) | 2.57 (0.48–13.77) | 0.57 (0.20 – 1.66) | .32 (.12-.87) |
Adjusted Model* | ||||
K55R | 5.48 (1.51–19.91) | 7.52 (1.27–44.46) | 0.49 (0.12–2.09) | 1.25 (0.30–5.20) |
R287Q | 0.56 (0.16–1.96) | 3.09 (0.51–18.52) | 0.56 (0.18 – 1.71) | 0.23 (0.06–0.82) |
Age | 1.00 (0.96–1.04) | 1.06 (1.00–1.14) | 0.98 (0.94–1.02) | 1.02 (0.98–1.06) |
Admission GCS | 0.91 (0.81–1.01) | 0.63 (0.68–0.99) | 0.86 (0.77–0.96) | 0.72 (0.62–0.84) |
GCS Glasgow coma scale, GOS Glasgow outcome scale
Data presented as Odds ratios with 95% confidence intervals OR (95% CI).